ARV Therapies and Therapeutic Strategies program is a comprehensive, expert review of the 15th European AIDS Conference (EACS 2015). This program consists of five components: (1) CME Internet Symposium: EACS 2015 Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) CME Internet Symposium: Brazilian Perspective on EACS 2015: a 1-hour Internet symposium featuring Brazil-based expert faculty reviewing and discussing key presentations with a focus on management and treatment in Brazil; (3) Comprehensive Expert Review and Discussion of Key Presentations: an on-line, in-depth review of 8 of the key poster/presentations reviewed in the Internet symposium; (4) Rapid-Fire Review of EACS 2015: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (5) From Conference to Clinic: Reviewing and Applying Data From EACS 2015: case-based dinner meetings during which the key data are reviewed, discussed and applied to patient care.
From Conference to Clinic: Reviewing and Applying Data From EACS 2015 is an interactive, case-based dinner program series designed to highlight and discuss the clinical significance and application of new findings in HIV medicine presented at EACS 2015. Because the focus of the dinner programs will be on case studies and applying the data presented at EACS 2015 in a clinical setting, prior to attending a dinner program participants will be asked to view the CME Internet Symposium: EACS 2015 Review, which will familiarize them with the EACS 2015 data and serve as a comprehensive conference overview and summary. As a result of this blended learning approach, participants will gain an increased understanding of key data presented at EACS 2015 and be better prepared to address their HIV patients' health needs and provide optimal care in a clinical setting.
All online components of the program will be accessible at www.viraled.com.
This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at EACS 2015 and it is not sanctioned by the organizers of EACS 2015.
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.
After completing this activity, the participant should be better able to:
|
Richard A. Elion, MD
|
Charles B. Hicks, MD Professor of Clinical Medicine Director, Owen Clinic University of California, San Diego San Diego, California |
|
Ian Frank, MD Professor of Medicine Director, Clinical Therapeutics Program Penn Center for AIDS Research Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania |
Michael Sension, MD Medical Director HIV Clinical Research Broward Health Fort Lauderdale, Florida |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
As of August 1, 2013, pharmaceutical companies are required by the open payments act (AKA Sunshine Act) to account for certain transfers of value provided to physicians. The federal guidance for the Sunshine Act provides exceptions for CME expenses that meet certain criteria. We believe the program to which you are invited meets these exceptions, and therefore we will not be collecting, nor reporting, any information gathered from this program. If federal guidance is further clarified in the future, we will then provide that information to the supporting pharmaceutical companies to the best of our ability.
This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.
